Clinical Trials for Emily Chan

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCPHI1342
02/11/2014
A Phase 1, First-in-Human Study Evaluating the Safety, Tolerability, and Pharmacokinetics of AMG 337 in Adult Subjects with Advanced Solid Tumors
TreatmentVICCPHI1359
12/03/2013
A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
TreatmentECOGGIS0820
09/03/2013
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III - Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)

Back to Find By Doctor

You do not have JavaScript enabled. This site works better with JavaScript turned on.